-
Something wrong with this record ?
Interleukin 6 and complement serum level study in Parkinson's disease
B. Veselý, M. Dufek, V. Thon, M. Brozman, S. Királová, T. Halászová, E. Koriťáková, I. Rektor,
Language English Country Austria
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Biomarkers blood MeSH
- Interleukin-6 blood MeSH
- Complement C4 analysis MeSH
- Complement C3 analysis MeSH
- Middle Aged MeSH
- Humans MeSH
- Longitudinal Studies MeSH
- Parkinson Disease blood immunology MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The objective of this study is to assess whether elevation of serum inflammatory markers levels may indicate the progression of clinical impairment in Parkinson's disease (PD) patients. In 47 PD patients, the serum levels of the C3 and C4 part of the complement and Interleukin-6 (IL-6) were measured. The results at baseline and after 2 years were correlated with scales measuring memory, depression, motor symptoms, and quality of life. Patients with higher levels of C3 and C4 at baseline had decreased quality of life, verbal ability, and memory. Patients with higher IL-6 at baseline showed worse depression scores at 2 years. Patients with persistently higher levels of C3 and C4 at 2 years had worse quality of life and memory ability. Uncorrected p values are reported due to the exploratory nature of the study. The results indicate an impact of inflammation on non-motor signs and quality of life in PD. The increase of levels of serum inflammatory biomarkers may indicate the progression of non-motor impairment in PD.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045553
- 003
- CZ-PrNML
- 005
- 20200115090946.0
- 007
- ta
- 008
- 200109s2018 au f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00702-018-1857-5 $2 doi
- 035 __
- $a (PubMed)29435648
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a au
- 100 1_
- $a Veselý, Branislav $u Department of Neurology, Faculty Hospital, Constantine the Philosopher University, Špitálska 6, 94901, Nitra, Slovak Republic. Central European Institute of Technology (CEITEC), Brain and Mind Research Programme, 625 00, Brno, Czech Republic.
- 245 10
- $a Interleukin 6 and complement serum level study in Parkinson's disease / $c B. Veselý, M. Dufek, V. Thon, M. Brozman, S. Királová, T. Halászová, E. Koriťáková, I. Rektor,
- 520 9_
- $a The objective of this study is to assess whether elevation of serum inflammatory markers levels may indicate the progression of clinical impairment in Parkinson's disease (PD) patients. In 47 PD patients, the serum levels of the C3 and C4 part of the complement and Interleukin-6 (IL-6) were measured. The results at baseline and after 2 years were correlated with scales measuring memory, depression, motor symptoms, and quality of life. Patients with higher levels of C3 and C4 at baseline had decreased quality of life, verbal ability, and memory. Patients with higher IL-6 at baseline showed worse depression scores at 2 years. Patients with persistently higher levels of C3 and C4 at 2 years had worse quality of life and memory ability. Uncorrected p values are reported due to the exploratory nature of the study. The results indicate an impact of inflammation on non-motor signs and quality of life in PD. The increase of levels of serum inflammatory biomarkers may indicate the progression of non-motor impairment in PD.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a komplement C3 $x analýza $7 D003176
- 650 _2
- $a komplement 4 $x analýza $7 D003181
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interleukin-6 $x krev $7 D015850
- 650 _2
- $a longitudinální studie $7 D008137
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a Parkinsonova nemoc $x krev $x imunologie $7 D010300
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dufek, Michal $u Movement Disorders Center, First Department of Neurology, Masaryk University, St. Anne's University Hospital, Pekařská 664/53, 656 91, Brno, Czech Republic.
- 700 1_
- $a Thon, Vojtech $u Department of Clinical Immunology and Allergy, Faculty of Medicine, Masaryk University, St. Anne's University Hospital, 656 91, Brno, Czech Republic.
- 700 1_
- $a Brozman, Miroslav $u Department of Neurology, Faculty Hospital, Constantine the Philosopher University, Špitálska 6, 94901, Nitra, Slovak Republic.
- 700 1_
- $a Királová, Silvia $u Department of Clinical Psychology, Faculty Hospital, Constantine the Philosopher University, Špitálska 6, 94901, Nitra, Slovak Republic.
- 700 1_
- $a Halászová, Tatiana $u Department of Clinical Psychology, Faculty Hospital, Constantine the Philosopher University, Špitálska 6, 94901, Nitra, Slovak Republic.
- 700 1_
- $a Koriťáková, Eva $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 123/3, 625 00, Brno, Czech Republic.
- 700 1_
- $a Rektor, Ivan $u Movement Disorders Center, First Department of Neurology, Masaryk University, St. Anne's University Hospital, Pekařská 664/53, 656 91, Brno, Czech Republic. irektor@med.muni.cz. Central European Institute of Technology (CEITEC), Brain and Mind Research Programme, 625 00, Brno, Czech Republic. irektor@med.muni.cz.
- 773 0_
- $w MED00010058 $t Journal of neural transmission (Vienna, Austria : 1996) $x 1435-1463 $g Roč. 125, č. 5 (2018), s. 875-881
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29435648 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200115091320 $b ABA008
- 999 __
- $a ok $b bmc $g 1483821 $s 1084226
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 125 $c 5 $d 875-881 $e 20180212 $i 1435-1463 $m Journal of neural transmission $n J Neural Transm $x MED00010058
- LZP __
- $a Pubmed-20200109